Get 20% lifetime commission for referring investors to digrin.com
here.
Talaris Therapeutics, Inc. (TALS) Financials
Stock symbol TALS is outdated, potentially delisted? Maybe it is available on other exchange?
TALS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2023 | 159.1 million | 10.7 million |
| March 31, 2023 | 172.6 million | 10.9 million |
| Dec. 31, 2022 | 193.7 million | 13.7 million |
| Sept. 30, 2022 | 206.5 million | 11.7 million |
TALS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2023 | -14.9 million | 1.2 million |
| March 31, 2023 | -17.2 million | 3.7 million |
| Dec. 31, 2022 | -14.1 million | 3.1 million |
| Sept. 30, 2022 | -13.8 million | 3.0 million |
TALS Net Income
No data available :(
TALS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2023 | 152.3 million | - | 1.0 million |
| March 31, 2023 | 165.8 million | - | 1.3 million |
| Dec. 31, 2022 | 181.3 million | - | 2.9 million |
| Sept. 30, 2022 | 193.9 million | - | 3.1 million |
TALS Shares Outstanding
TALS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2023 | 221000 | 4.1 million | 6.0 million | - |
| March 31, 2023 | 320000 | 13.4 million | 6.2 million | - |
| Dec. 31, 2022 | 269000 | 14.6 million | 5.2 million | - |
| Sept. 30, 2022 | 341000 | 15.0 million | 4.8 million | - |
TALS Cost of Revenue
No data available :(
TALS
Price: $2.72
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.8 million
Market Capitalization: 125.7 million